Sowell Financial Services LLC purchased a new position in shares of JPMorgan BetaBuilders Canada ETF (BATS:BBCA – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 6,489 shares of the company’s stock, valued at approximately $651,000.
Several other hedge funds have also made changes to their positions in BBCA. Quadrant Capital Group LLC purchased a new position in JPMorgan BetaBuilders Canada ETF during the third quarter worth about $1,052,000. Sumitomo Mitsui DS Asset Management Company Ltd purchased a new stake in JPMorgan BetaBuilders Canada ETF in the 3rd quarter valued at about $838,000. TD Waterhouse Canada Inc. grew its holdings in JPMorgan BetaBuilders Canada ETF by 30.6% in the 3rd quarter. TD Waterhouse Canada Inc. now owns 19,111 shares of the company’s stock valued at $1,914,000 after buying an additional 4,477 shares during the period. Curated Wealth Partners LLC acquired a new position in shares of JPMorgan BetaBuilders Canada ETF during the 3rd quarter valued at about $378,000. Finally, Mather Group LLC. acquired a new position in shares of JPMorgan BetaBuilders Canada ETF during the 3rd quarter valued at about $58,000.
JPMorgan BetaBuilders Canada ETF Price Performance
Shares of BBCA stock opened at $104.89 on Tuesday. The firm has a market cap of $10.85 billion, a P/E ratio of 19.87 and a beta of 0.95. JPMorgan BetaBuilders Canada ETF has a 1-year low of $84.87 and a 1-year high of $108.06. The firm’s 50-day simple moving average is $104.00 and its 200-day simple moving average is $100.34.
JPMorgan BetaBuilders Canada ETF Profile
The JPMorgan BetaBuilders Canada ETF (BBCA) is an exchange-traded fund that mostly invests in total market equity. The fund tracks a market cap-weighted index of large- and mid-cap Canadian equities. BBCA was launched on Aug 7, 2018 and is managed by JPMorgan Chase.
Read More
- Five stocks we like better than JPMorgan BetaBuilders Canada ETF
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for JPMorgan BetaBuilders Canada ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan BetaBuilders Canada ETF and related companies with MarketBeat.com's FREE daily email newsletter.
